Clinical Trial Finds Psilocybin Eases Depression in Cancer Patients
Clinical trial results reveal that a single dose of psilocybin can significantly reduce depression and anxiety in cancer patients, with effects lasting up to two years. Larger studies are underway to confirm its therapeutic potential.
Recent clinical trial results have demonstrated that a single dose of psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, can offer long-lasting relief from depression and anxiety for individuals battling cancer. The study, published in the journal Cancer, involved 28 patients diagnosed with cancer and major depressive disorder. Participants received psychological support before, during, and after administering a 25-mg dose of psilocybin.
Follow-up assessments conducted two years later revealed significant benefits: over half of the patients experienced substantial reductions in depression, with nearly half maintaining remission. Additionally, about 43% of patients showed decreased anxiety levels. The findings suggest that psilocybin can have enduring antidepressant effects following just a single dose.
An ongoing double-blind trial is now exploring whether up to two doses of psilocybin at 25 mg can further improve outcomes in depression and anxiety among cancer patients. This larger study aims to determine if repeated dosing can increase the rate of remission.
Lead researcher Dr. Manish Agrawal from Sunstone Therapies highlighted the potential of psilocybin, noting that it could become a valuable treatment option for depression in cancer patients if further studies confirm these promising results. The research builds on previous work indicating the long-term mental health benefits of psilocybin, and ongoing investigations may pave the way for its broader use in supportive cancer care.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
High Schoolers’ Mental Health Challenges Rising, Particularly Among Girls and Gender-Diverse Teens
A new large-scale study reveals that nearly a quarter of high school students experience mental health problems, with heightened risks among girls and gender-diverse teens. The findings underscore the urgent need for targeted prevention and support programs to improve adolescent mental well-being.
Adolescent ADHD Symptoms and Their Indirect Impact on Adult Income via Education and Mental Health
A new study reveals that adolescent ADHD and ODD symptoms affect adult income indirectly through education and mental health, highlighting the importance of early intervention and support.
Recognizing When Winter Fatigue May Signal a More Serious Condition
Feeling persistently low and tired during winter may signal seasonal affective disorder, a treatable form of depression. Learn about symptoms, causes, and effective treatments.